{"id":2937,"date":"2021-06-07T09:24:08","date_gmt":"2021-06-07T07:24:08","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=2937"},"modified":"2021-06-07T09:24:08","modified_gmt":"2021-06-07T07:24:08","slug":"linfoma-cutaneo-primario-y-covid-19","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2021\/06\/07\/linfoma-cutaneo-primario-y-covid-19\/","title":{"rendered":"Linfoma cut\u00e1neo primario Y COVID-19"},"content":{"rendered":"<p data-adtags-visited=\"true\">Alba S\u00e1nchez y Pablo Ortiz son dos de los autores de una carta al editor publicada en el <em>Journal of the European Academy of Dermatology and Venereology <\/em>acerca del<img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=246&amp;h=163\" srcset=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=246&amp;h=163&amp;zoom=2 1.5x\" alt=\"logo12\" width=\"246\" height=\"163\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/> <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/epdf\/10.1111\/jdv.17430\" target=\"_blank\" rel=\"noopener\">riesgo de sufrir COVID m\u00e1s grave aquellos pacientes con linfoma cut\u00e1neo primario<\/a>.<\/p>\n<p data-adtags-visited=\"true\">Los datos se han obtenido del Registro Espa\u00f1ol de Linfoma Cut\u00e1neo Primario, con informaci\u00f3n de 27 centros sanitarios, y han permitido analizar la incidencia de COVID-19 en una cohorte de pacientes con LCP, analizando sus caracter\u00edsticas cl\u00ednicas y evoluci\u00f3n, en comparaci\u00f3n con la poblaci\u00f3n general. El registro recoge datos de 1.542 pacientes, de los cuales el 4% sufri\u00f3 COVID-19. La mayor\u00eda experiment\u00f3 una enfermedad leve, el 25% necesit\u00f3 hospitalizaci\u00f3n y el 5% ingreso en UCI. El 82% de los pacientes inform\u00f3 de estabilidad en su LCP, el 9% mejora y el 9% empeoramiento. No se ha podido detectar un aumento de los riesgos en todos los pacientes con LCP en comparaci\u00f3n con la poblaci\u00f3n general, excepto en el rango de edad de 60 a 69 a\u00f1os, donde el estudio inclu\u00eda m\u00e1s pacientes y resultados ofreciendo as\u00ed m\u00e1s poder estad\u00edstico. Este estudio sugiere que los pacientes con LCP deben considerarse en riesgo de COVID-19 grave, lo que supone reforzar las medidas preventivas y asegurar su vacunaci\u00f3n.<\/p>\n<p data-adtags-visited=\"true\"><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Alba S\u00e1nchez y Pablo Ortiz son dos de los autores de una carta al editor publicada en el Journal of the European Academy of Dermatology and Venereology acerca del riesgo de sufrir COVID m\u00e1s grave aquellos pacientes con linfoma cut\u00e1neo primario. Los datos se han obtenido del Registro Espa\u00f1ol de \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2021\/06\/07\/linfoma-cutaneo-primario-y-covid-19\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-Ln","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2937"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=2937"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2937\/revisions"}],"predecessor-version":[{"id":2938,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2937\/revisions\/2938"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=2937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=2937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=2937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}